Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q2 2023 Earnings

8AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-1.45

-1.25

-1.04

-0.84

Details

Expected EPS

-0.9

Actual EPS

-0.84

Surprise EPS

0.06

Surprise Percent

+6.67%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.84 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.